It may pay for us to do some research on Osiris and its product, as well as re-read the life scientist material and compare data. From memory Osiris objective for Phase 2 trial was met?
Agree positive/great news would be in our favour.
Just a few snippets not comprehensive as it is late and I should be in bed!
http://www.osiris.com/prod_diabetes.php - Pre-clinical studies first conducted by researchers at Genzyme found that MSCs may have the ability to delay the progression of type 1 diabetes by preserving beta cell function.
http://www.osiris.com/clinical_prochymal_t1dm.php The objective of this Phase 2 study is to evaluate the efficacy and safety of Prochymal in those patients who have been recently diagnosed with type 1 diabetes mellitus (T1DM). T1DM, or juvenile diabetes, is an autoimmune disorder where the immune system attacks and destroys the beta cell
http://www.lifescientist.com.au/article/407018/mesoblast_posts_successful_results_from_diabetes_stem_cell_trial/
“Intravenous injection of our MPCs may not only improve blood glucose control, it may concomitantly reduce the significant risk of heart attacks and death that occurs in patients with Type 2 diabetes,” said Mesoblast CEO, Professor Silviu Itescu. in the pancreas.
- Forums
- ASX - By Stock
- competitor does not cut the mustard
It may pay for us to do some research on Osiris and its product,...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 20225 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 0.945 |
6 | 52140 | 0.940 |
8 | 92185 | 0.935 |
5 | 73150 | 0.930 |
4 | 51132 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 20225 | 5 |
0.955 | 42472 | 3 |
0.960 | 80775 | 4 |
0.965 | 57967 | 5 |
0.970 | 73641 | 5 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online